Bal Pharma Ltd

NSE: BALPHARMA · BSE: 524824 · Pharmaceuticals & Biotechnology · 32 announcements

Share price: ₹99.80
Market cap: ₹158.9 Cr
Revenue (annual): ₹311.7 Cr
Net profit (annual): ₹6.28 Cr
P/E (TTM): 22.1×Sector 47.4×
Promoter holding: 50.86%+0.00% QoQ
FII holding: 0.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 7 Other Announcement 5 Management Change 4 Financial Results 3 Capital Structure Change 3 Dividend 2 Board Meeting Date 2 Price Movement Clarification 1 Merger & Restructuring 1 Legal & Regulatory 1 Fund Raise 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

5 Aug 2026 16:09 IST BSE

Board Meeting Date

Bal Pharma Board Meeting Date

Bal Pharma Limited has scheduled a board meeting on August 12, 2026, to consider and approve its unaudited standalone and consolidated financial results for Q1/2026-27.

Read the filing ↗

18 May 2026 15:13 IST BSE

Board Meeting Date

Bal Pharma Board Meeting Date

Bal Pharma scheduled a board meeting for May 27, 2026, to approve audited financial results and recommend a dividend. The trading window remains closed until May 29.

Read the filing ↗